Oncogene addiction: setting the stage for molecularly targeted cancer therapy

SV Sharma, J Settleman - Genes & development, 2007 - genesdev.cshlp.org
In pugilistic parlance, the one-two punch is a devastating combination of blows, with the first
punch setting the stage and the second delivering the knock-out. This analogy can be …

WWOX: its genomics, partners, and functions

S Del Mare, Z Salah, RI Aqeilan - Journal of cellular …, 2009 - Wiley Online Library
The WW domain‐containing oxidoreductase (WWOX) spans one of the most active common
fragile sites (CFSs) involved in cancer, FRA16D. WWOX encodes a 46‐kDa protein that …

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

M Fabbri, R Garzon, A Cimmino, Z Liu… - Proceedings of the …, 2007 - National Acad Sciences
MicroRNAs (miRNAs) are small, noncoding RNAs that regulate expression of many genes.
Recent studies suggest roles of miRNAs in carcinogenesis. We and others have shown that …

Targeted deletion of Wwox reveals a tumor suppressor function

RI Aqeilan, F Trapasso, S Hussain… - Proceedings of the …, 2007 - National Acad Sciences
The WW domain-containing oxidoreductase (WWOX) spans the second most common
fragile site of the human genome, FRA16D, located at 16q23, and its expression is altered in …

A comparison and catalog of intrinsic tumor growth models

EA Sarapata, LG De Pillis - Bulletin of mathematical biology, 2014 - Springer
Determining the mathematical dynamics and associated parameter values that should be
used to accurately reflect tumor growth continues to be of interest to mathematical modelers …

miR‐134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene

CJ Liu, WG Shen, SY Peng, HW Cheng… - … journal of cancer, 2014 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is a prevalent disease worldwide, and
the survival of HNSCC has not improved significantly over the last few decades. MicroRNAs …

[PDF][PDF] Lentivirus‐mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down‐regulation of stathmin

Y Chen, MC Lin, H Yao, H Wang, AQ Zhang, J Yu… - …, 2007 - Wiley Online Library
Enhancer of zeste homolog 2 (EZH2) has been shown to be overexpressed in
hepatocellular (HCC). We investigated the potential role of EZH2 in HCC tumorigenesis and …

Gene map** and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple …

MW Jenner, PE Leone, BA Walker… - Blood, The Journal …, 2007 - ashpublications.org
We performed fluorescent in situ hybridization (FISH) for 16q23 abnormalities in 861
patients with newly diagnosed multiple myeloma and identified deletion of 16q [del (16q)] in …

RETRACTED ARTICLE: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling …

CH Wei, G Wu, Q Cai, XC Gao, F Tong, R Zhou… - Journal of hematology & …, 2017 - Springer
Background Brain metastasis (BM) is associated with poor prognosis in patients with non-
small cell lung cancer (NSCLC). Recent studies demonstrated that microRNA-330-3p (miR …

[HTML][HTML] Serum microRNA signature is capable of early diagnosis for non-small cell lung cancer

X Yang, Q Zhang, M Zhang, W Su, Z Wang… - … Journal of Biological …, 2019 - ncbi.nlm.nih.gov
Despite decades of efforts, non-small-cell lung cancer (NSCLC) remains the leading cause
of cancer mortality globally primarily due to the challenge in early detection of the cancer …